During the last session, Biofrontera Inc (NASDAQ:BFRI)’s traded shares were 0.5 million, with the beta value of the company hitting 0.48. The 52-week high for the BFRI share is $9.52, that puts it down -643.75 from that peak though still a striking 52.34% gain since the share price plummeted to a 52-week low of $0.61. The company’s market capitalization is $7.09M, and the average intraday trading volume over the past 10 days was 0.47 million shares, and the average trade volume was 200.72K shares over the past three months.
Biofrontera Inc (BFRI) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. BFRI has a Sell rating from 0 analyst(s) out of 2 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 2 recommend a Buy rating for it.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Biofrontera Inc (NASDAQ:BFRI) trade information
The stock’s 5-day price performance is -0.78%, and it has moved by 5.79% in 30 days. Based on these gigs, the overall price performance for the year is -85.08%. The short interest in Biofrontera Inc (NASDAQ:BFRI) is 35524.0 shares and it means that shorts have 0.17 day(s) to cover.
Biofrontera Inc (BFRI) estimates and forecasts
Statistics show that Biofrontera Inc has outperformed its competitors in share price, compared to the industry in which it operates. Biofrontera Inc (BFRI) shares have gone up 2.40% during the last six months, with a year-to-date growth rate more than the industry average at 81.51% against 17.30.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 7.90%. While earnings are projected to return 75.31% in 2024.
BFRI Dividends
Biofrontera Inc is due to release its next quarterly earnings on 2024-Nov-09. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Biofrontera Inc (NASDAQ:BFRI)’s Major holders
Biofrontera Inc insiders own 32.06% of total outstanding shares while institutional holders control 38.34%, with the float percentage being 56.44%.
Also, the Mutual Funds coming in first place with the largest holdings of Biofrontera Inc (BFRI) shares are Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund . Data provided on Jul 31, 2024 indicates that Fidelity Extended Market Index Fund owns about 15.38 shares. This amounts to just over 0.28 percent of the company’s overall shares, with a $19688.0 market value. The same data shows that the other fund manager holds slightly less at 8.61, or about 0.16% of the stock, which is worth about $11022.0.
